Fuso Pharmaceutical Industries,Ltd. 4538Short Interest

No institution currently reports a short position of 0.5% or more in Fuso Pharmaceutical Industries,Ltd. (4538). The last disclosure was on 2026-10-29 (Barclays Capital Securities Ltd, 0.00%).

Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 2
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
41 reports

Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 2 institutions that fell below 0.5%. How estimates are calculated

Disclosure History Summary

First disclosure2023-12-18
Latest disclosure2026-10-29 (Barclays Capital Securities Ltd, 0.00%)
Reporting institutions3 firms (41 reports)
Peak estimated short interest1.13% (2025-09-17, 1 holders)

Short Interest Trend Last 5 years, by institution, % of shares outstanding

Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 3 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.

  • Barclays Capital Securities Ltd
  • Nomura International plc
  • MERRILL LYNCH INTERNATIONAL
0.00%
Estimated short interest, 2026-11-18

Current Positions by Short Seller Latest report of each holder

Last report Short seller Position (shares) Ratio Change Status
2023-12-22 MERRILL LYNCH INTERNATIONAL Position 46,862 shares Ratio 0.49% ▼0.01% −600 Below 0.5%
2024-01-16 Nomura International plc Position 41,300 shares Ratio 0.43% ▼0.09% −7,900 Below 0.5%
2026-10-29 Barclays Capital Securities Ltd Position 102 shares Ratio 0.00% ▼0.69% −65,300 Closed

Disclosure History 41 in total

Trade date Short seller Position (shares) Ratio Change Note
2026-10-29 Barclays Capital Securities Ltd Position 102 shares Ratio 0.00% ▼0.69% −65,300 Closed
2026-10-28 Barclays Capital Securities Ltd Position 65,402 shares Ratio 0.69% ▼0.01% −1,100 —
2026-10-23 Barclays Capital Securities Ltd Position 66,502 shares Ratio 0.70% ▲0.08% +7,100 —
2026-10-20 Barclays Capital Securities Ltd Position 59,402 shares Ratio 0.62% ▲0.03% +2,800 —
2026-10-09 Barclays Capital Securities Ltd Position 56,602 shares Ratio 0.59% ▼0.01% −700 —
2026-10-08 Barclays Capital Securities Ltd Position 57,302 shares Ratio 0.60% ▲0.01% +1,500 —
2026-10-07 Barclays Capital Securities Ltd Position 55,802 shares Ratio 0.59% ▼0.10% −10,330 —
2026-10-05 Barclays Capital Securities Ltd Position 66,132 shares Ratio 0.69% ▲0.40% +21,032 —
2026-08-28 Barclays Capital Securities Ltd Position 45,100 shares Ratio 0.47% ▼0.12% −11,570 Below 0.5%
2026-08-19 Barclays Capital Securities Ltd Position 56,670 shares Ratio 0.59% ▼0.09% −8,130 —
2026-08-17 Barclays Capital Securities Ltd Position 64,800 shares Ratio 0.68% ▼0.05% −5,000 —
2026-08-14 Barclays Capital Securities Ltd Position 69,800 shares Ratio 0.73% ▼0.15% −13,602 —
2026-07-29 Barclays Capital Securities Ltd Position 83,402 shares Ratio 0.88% ▼0.03% −3,400 —
2026-07-16 Barclays Capital Securities Ltd Position 86,802 shares Ratio 0.91% ▲0.02% +11,446 —
2026-06-29 Barclays Capital Securities Ltd Position 75,356 shares Ratio 0.79% ▼0.10% −9,400 —
2026-06-12 Barclays Capital Securities Ltd Position 84,756 shares Ratio 0.89% ▼0.05% −4,400 —
2026-06-02 Barclays Capital Securities Ltd Position 89,156 shares Ratio 0.94% ▲0.13% +12,100 —
2026-05-25 Barclays Capital Securities Ltd Position 77,056 shares Ratio 0.81% ▲0.07% +7,099 —
2026-05-13 Barclays Capital Securities Ltd Position 69,957 shares Ratio 0.74% ▲0.23% +21,700 —
2026-05-11 Barclays Capital Securities Ltd Position 48,257 shares Ratio 0.51% ▼0.10% −9,999 —
2026-05-08 Barclays Capital Securities Ltd Position 58,256 shares Ratio 0.61% ▲0.09% +8,801 —
2026-04-20 Barclays Capital Securities Ltd Position 49,455 shares Ratio 0.52% ▲0.08% +7,699 —
2026-04-15 Barclays Capital Securities Ltd Position 41,756 shares Ratio 0.44% ▼0.06% −6,300 Below 0.5%
2026-04-14 Barclays Capital Securities Ltd Position 48,056 shares Ratio 0.50% ▲0.08% +1,215 —
2026-02-16 Barclays Capital Securities Ltd Position 46,841 shares Ratio 0.49% ▼0.02% −1,700 Below 0.5%
2026-02-12 Barclays Capital Securities Ltd Position 48,541 shares Ratio 0.51% ▲0.07% +48,541 —
2025-09-19 Barclays Capital Securities Ltd Position 0 shares Ratio 0.00% ▼1.13% −107,441 Closed
2025-09-17 Barclays Capital Securities Ltd Position 107,441 shares Ratio 1.13% ▲0.10% +9,400 —
2025-09-11 Barclays Capital Securities Ltd Position 98,041 shares Ratio 1.03% ▲0.13% +12,700 —
2025-09-08 Barclays Capital Securities Ltd Position 85,341 shares Ratio 0.90% ▲0.08% +7,500 —

Shorted Stocks in the Same Industry Pharmaceutical

Stock Estimated ratio Short sellers
GNI Group Ltd.2160 11.16% 7 firms
Oncolys BioPharma Inc.4588 10.35% 7 firms
HEALIOS K.K.4593 10.20% 5 firms
SymBio Pharmaceuticals Limited4582 9.46% 7 firms
Nxera Pharma Co.,Ltd.4565 7.35% 5 firms

Related Stocks Same TSE 33 sector

Stock Market TSE 33 Sector TOPIX-17 Sector Index
KAKEN PHARMACEUTICAL CO.,LTD.4521 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
Eisai Co.,Ltd.4523 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
ROHTO PHARMACEUTICAL CO.,LTD.4527 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
ONO PHARMACEUTICAL CO.,LTD.4528 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
SANTEN PHARMACEUTICAL CO.,LTD.4536 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
NIPPON CHEMIPHAR CO.,LTD.4539 Standard Market(Domestic) Pharmaceutical Pharmaceutical
TSUMURA & CO.4540 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
KISSEI PHARMACEUTICAL CO.,LTD.4547 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
SEIKAGAKU CORPORATION4548 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 2
EIKEN CHEMICAL CO.,LTD.4549 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1